FABP1 and metabolic syndrome: Studies on FABPs revealed that the plasma levels of Fabp4 were elevated in metabolic syndrome patients (44, 45) and the Fabp1 null mice showed sex- and age-dependent weight gain as well as increased fat tissue mass (46).